Publications Archive - Page 4 of 8 - KalVista Pharmaceuticals

Showing 31-40 out of 74

Trends in Volume of On-demand Hereditary Angioedema Treatments in the US: A Retrospective Analysis of a Large Multi-payer Claims Database

Soteres DF, Maheshwari C, Sharma A, Wang A, Audhya PK, Tachdjian R
EAC 2024

Real-world Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

Craig T, Busse P, Christiansen S, O’Connor M, Radojicic C, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V
EAC 2024

Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database Analysis

Tachdjian R, Soteres D, Chang R, Mohan M, Pinaire M, DerSarkissian M, Desai V, Wang A, Audhya P
EAC 2024

Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

O’Connor M, Busse P, Craig T, Radojicic C, Christiansen S, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V
EAC 2024

Burden of Untreated Hereditary Angioedema Attacks and its Impact on Social, Mental, and Physical Health

Radojicic C, Busse P, Maeve O’Connor3, Ulloa J, Danese S, Desai V,Andriotti T, Audhya P, Christiansen S
EAC 2024

Burden of Untreated Hereditary Angioedema Attacks Impact on Social, Mental, and Physical Health

Radojicic C, Busse P, O’Connor M, Ulloa J, Danese S, Desai V, Andriotti T, Audhya P, Christiansen S

ISPOR 2024

Real-world Impact of Treated Hereditary Angioedema Attacks on Patients’ Work Productivity and Ability to do Daily Activities

Craig T, Busse P, Christiansen S, O’Connor M, Radojicic C, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V

ISPOR 2024

Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

Busse P, Craig T, Radojicic C, O’Connor M, Christiansen S, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V

ISPOR 2024

Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database Analysis

Tachdjian R, Soteres D, Chang R, Mohan M, Pinaire M, DerSarkissian M, Desai V, Wang A, Audhya P

ISPOR 2024

Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema

Feener EP, Davie RL, Murugesan N, Pethen SJ, Hampton SL, Smith MD, Audhya PK, Yea CM

Drugs and Drug Candidates

About

Science

Pipeline

Careers

Contact